期刊文献+

不同剂量阿托伐他汀对心房颤动患者hs-CRP、NO、IL-6、脂联素水平的影响 被引量:6

Effects of high dosage Atorvastatin on hs-CRP, NO, IL-6, adiponectin in patients with atrial fibrillation
下载PDF
导出
摘要 目的 观察不同剂量阿托伐他汀对房颤患者hs-CRP、NO、IL-6、脂联素水平的影响.方法 选取合肥市第三人民医院2012年12月至2014年2月住院的房颤患者80例,随机分为20 mg阿托伐他汀组和40 mg阿托伐他汀组,每组40例,观察两组患者治疗前后超敏C-反应蛋白(hs-C RP)、一氧化氮(NO)、白细胞介素-6(IL-6)、脂联素和左房内径的变化.结果 治疗前、后,20 mg阿托伐他汀组hs-CRP水平分别为(6.25±1.75)mg/L和(5.23±1.85)mg/L,IL-6水平分别为(14.53±2.32)ng/L和(13.02±2.12)ng/L;40 mg阿托伐他汀组hs-CRP水平分别为(6.45±1.65)mg/L和(4.25± 1.72)mg/L,IL-6水平分别为(14.65±2.42)ng/L和(11.12±1.25)ng/L.两组治疗后各项水平均明显降低,与治疗前比较差异有统计学意义(P<0.05),且40 mg阿托伐他汀组降低更明显,与20 mg阿托伐他汀组比较差异有统计学意义(P<0.05).20 mg阿托伐他汀组NO水平治疗前后分别为(26.30±1.65)mmol/L和(35.25±1.78)mmol/L,脂联素水平分别为(7.26±3.25)μg/L和(8.56±3.12)μg/L.两组治疗后各项水平均明显升高,与治疗前比较差异有统计学意义(P<0.05),且40 mg阿托伐他汀组升高更明显,与20 mg阿托伐他汀组比较差异有统计学意义(P<0.05).结论 大剂量阿托伐他汀能显著改变房颤患者血清炎症因子水平,且呈剂量依赖性. Objective To observe the different doses of Atorvastatin effects on patients with atrial fibrillation hs-CRP,NO,IL-6,adiponectin levels.Methods AF patients hospitalized in Third People's Hospital of Hefei from December 2012 to February 2014,80 patients were randomly divided into 20 mg Atorvastatin group and 40 mg Atorvastatin groups of 40 cases observed two groups of patients hypersensitive C-reactive protein (hs-CRP),nitric oxide(NO),interleukin-6(IL-6),changes in adiponectin and changes in left atrial diameter before and after treatment.Results After treatment,20 mg Atorvastatin group hs-CRP levels before and after treatment was (6.25±1.75)mg/L,(5.23±1.85)mg/L,IL-6 levels before and after treatment was(14.53±2.32)ng/L,(13.02±2.12)ng/L.40 mg Atorvastatin group hs-CRP levels before and after treatment was (6.45±1.65)mg/L,(4.25±1.72)mg/L,IL-6 levels before and after treatment was (14.65±2.42)g/L,(11.12±1.25)g/L,before and after treatment were significantly lower (P〈0.05),and 40 mg Atorvastatin reduced more significantly (P〈0.05).20 mg Atorvastatin group before and after treatment was significantly higher NO (26.30±1.65)mmol/L,(35.25±1.78) mmol/L,adiponectin levels before and after treatment was(7.26±3.25)μg/L,(8.56±3.12)μg/L,before and after treatment were significantly increased (P〈0.05),and 40 mg Atorvastatin group increased more significantly (P〈 0.05).Conclusion Large dose Atorvastatin significantly alter the serum levels of inflammatory cytokines in patients with atrial fibrillation,a dose-dependent manner.
出处 《中国心血管病研究》 CAS 2014年第12期1106-1108,共3页 Chinese Journal of Cardiovascular Research
关键词 心房颤动 阿托伐他汀 炎症因子 Atrial fibrillation Atorvastatin Inflammatory cytokines
  • 相关文献

参考文献13

  • 1Boos C J, Anderson RA, Lip GY. Is atrial fibrillation an inflam- matory disorder? Eur Heart J, 2006,27 : 136-149. 被引量:1
  • 2边波,孙跃民,万征.他汀类药的抗心律失常作用:从临床循证证据到分子机制[J].中国心脏起搏与心电生理杂志,2009,23(5):377-381. 被引量:37
  • 3李满生,王会霞,石建克,蔡华,张晓华,李新峰,岳修宇.阿托伐他汀钙在胺碘酮转复持续性心房颤动中的作用观察[J].中国心脏起搏与心电生理杂志,2011,25(5):411-413. 被引量:13
  • 4Psychari SN, Apostolou TS, Sinos L, et al. Relation of elevated Creative protein and interleukin-6 levels to left atrial size and duration of episodes in patents inwith atrial fibrillation. Am J cardiol, 2005,95 : 764-767. 被引量:1
  • 5Watanable T, Takeishi Y, Hirono O, et al. C-reactive protein elevation predictes the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation. Heart Vessels, 2005,20 : 45-49. 被引量:1
  • 6Aviles R.I, Matin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation,2003,108: 3006-30010. 被引量:1
  • 7赵宇,杨莉莉,康晓新,尹璐.C反应蛋白与心房颤动的关系[J].中国心血管病研究,2005,3(7):524-525. 被引量:9
  • 8Dernellis J, Panaretou M. C-reactive protein and paroxysm mala- trial fibrillation: evidence of the implication of anin flammatory processin paroxysmal atrial fibrillation. Acta cardiol, 2001,56 : 375-380. 被引量:1
  • 9Klein RM, Vester EG, Brehm MU, et al. Inflammation of the myocardium as an arrhythmia trigger. Z Kardiol, 2000,89:24-35. 被引量:1
  • 10Watanabe E, Arakawa T, Uchiyama T, et al. High-sensitivity c-reactive protein is predictive of successful eardioversion for atrial fibrillation and maintenance of sinus rhythm after eonversion.Int J Cardiol,2006,108 : 346-353. 被引量:1

二级参考文献58

  • 1商丽华,胡大一,赵秀丽.普伐他汀对快速起搏心房肌离子通道的作用[J].中国医药导刊,2004,6(3):192-194. 被引量:3
  • 2刘岩,邹大进,李慧,陈月,丁继军,郑兴,郭鹏飞.低脂联素血症是冠状动脉粥样硬化严重程度的重要标志[J].中华内分泌代谢杂志,2005,21(1):5-8. 被引量:111
  • 3张闽,杨晔.脂联素与动脉粥样硬化[J].海军总医院学报,2006,19(3):160-163. 被引量:1
  • 4周友根.阿托伐他汀联合胺碘酮治疗特发性阵发性心房颤动的研究[J].海南医学,2007,18(2):35-36. 被引量:3
  • 5Frustaci A, Chimenti C, Bellocei F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation [ J ]. Circulation, 1997, 96(4) : 1180-1184. 被引量:1
  • 6Thambidorai SK, A_nand K, Hee Tr, et al. Hydroxymethylglutaryl coenzyme a inhibitors ( Statins ) and arrhythmias : systematic Review and Meta-Analysis [ J ]. The Internet Journal of Cardiology (网络版) ,2009,6(2). 被引量:1
  • 7Young XY,Jabbour S, Goldberg R, et al. Usefulness of statin drugs in protecting against atrial fibrilation in patients with coronary artery disease[ J]. Am J Cardiol,2003,92 ( 12 ) : 1 379. 被引量:1
  • 8Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery : results of the ARM YDA-3 ( atorvastatin for reduction of myocardial dysrhythmia after cardiac surgery) study [ J ]. Circulation,2006,114 ( 14 ) : 1 455. 被引量:1
  • 9Marin F, Pascral DA, Roldan V, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting[ J ]. Am J Cardiol,2006,97 ( 1 ) :55. 被引量:1
  • 10Ozaydin M, Dogan A, Varol E, et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation [ J ]. Cardiology,2006,107 (2) : 117. 被引量:1

共引文献60

同被引文献75

  • 1刘健,王昭,王伟民.2012欧洲ST段抬高急性心肌梗死患者管理指南解读[J].中国医学前沿杂志(电子版),2013,5(2):55-60. 被引量:16
  • 2Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases[J]. Med Hypotheses, 2004,62(4):499-506. 被引量:1
  • 3European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) [J]. Eur Heart J, 2011,32(14):1769-1818. 被引量:1
  • 4Ostadal P, Alan D, Hajek P, et al. The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in the patients with unstable angina and non-Q-wave myocardial infarction[J]. Mol Cell Biochem, 2003,246(1-2):45-50. 被引量:1
  • 5Gore JM, Goldberg RJ, Matsumoto AS, et al. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction[J]. Am J Cardiol, 1984,54(7):722-725. 被引量:1
  • 6Vaisar T, Pennathur S, Green PS, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL[J]. J Clin Invest, 2007,117(3):746-756. 被引量:1
  • 7Kotseva K, Wood D, De Backer G, et al. EUROASPIRE Ⅲ: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries[J]. Eur J Cardiovasc Prev Rehabil, 2009,16(2):121-137. 被引量:1
  • 8De Luca G, Navarese EP, Cassetti E, et al. Meta-analysis of randomized trials of glycoprotein Ⅱb/Ⅲa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy[J]. Am J Cardiol, 2011,107(2):198-203. 被引量:1
  • 9Jergovic M,Bendelja K,Savic-Mlakar A,et al.Circulating levels of hormones,lipids,and immune mediators in post-traumatic stress disorder-a 3-month follow-up study[J].Front Psychiatry,2015,6(2):49. 被引量:1
  • 10Simsek S,Uysal C,Kaplan I,et al.BDNF and Cortisol levels in children with or without post-traumatic stress disorder after sustaining sexual abuse[J].Psychoneuroendocrinology,2015,56(4):45-51. 被引量:1

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部